EDOCAL

Early Detection Of CAncer using photonic crystal Lasers

Coordinatore	2M Engineering Limited    more  Organization address address: SIDNEY STREET 80 city: FOLKSTONE postcode: CT19 6HQ contact info Titolo: Ms. Nome: Gillian Cognome: Mimnagh Email: send email Telefono: 31 40 2982020 Fax: 31 40 2982164
Nazionalità Coordinatore	United Kingdom [UK]
Sito del progetto	http://www.edocal.eu
Totale costo	1˙805˙664 €
EC contributo	1˙448˙715 €
Programma	FP7-SME Specific Programme "Capacities": Research for the benefit of SMEs
Code Call	FP7-SME-2008-1
Funding Scheme	BSG-SME
Anno di inizio	2010
Periodo (anno-mese-giorno)	2010-01-01   -   2011-12-31

 Partecipanti

#	participant	country	role	EC contrib. [€]
1	2M Engineering Limited  Organization address address: SIDNEY STREET 80 city: FOLKSTONE postcode: CT19 6HQ contact info Titolo: Ms. Nome: Gillian Cognome: Mimnagh Email: send email Telefono: 31 40 2982020 Fax: 31 40 2982164	UK (FOLKSTONE)	coordinator	1˙184˙715.00
2	COMPOUND SEMICONDUCTOR TECHNOLOGIES GLOBAL LIMITED  Organization address address: "Block 6, West of Scotland Science Park, Maryhill Road" city: Glasgow postcode: G20 0SP contact info Titolo: Dr. Nome: Wyn Cognome: Meredith Email: send email Telefono: +44 141 579 3006	UK (Glasgow)	participant	102˙000.00
3	TOP-GAN SP ZOO  Organization address address: UL. SOKOLOWSKA 29/37 city: WARSZAWA postcode: 01 142 contact info Titolo: Prof. Nome: Michal Cognome: Leszczynski Email: send email Telefono: +48 8760310 Fax: +48 22 8760314	PL (WARSZAWA)	participant	80˙000.00
4	Academisch Medisch Centrum bij de Universiteit van Amsterdam  Organization address address: MEIBERGDREEF 9 city: AMSTERDAM postcode: 1105AZ contact info Titolo: Dr. Nome: Jacques Cognome: Bergman Email: send email Telefono: +31 20 5659087 Fax: +31 20 5669156	NL (AMSTERDAM)	participant	41˙000.00
5	Tayside Health Board  Organization address address: "Kings Cross, Clepington Road" city: Dundee postcode: DD3 8EA contact info Titolo: Dr. Nome: Harry Cognome: Moseley Email: send email Telefono: 01382 660111	UK (Dundee)	participant	41˙000.00

Mappa

 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

 Obiettivo del progetto (Objective)

'In Europe there are 3 million new cancer cases per year. According to the WHO the burden of cancer can be reduced by systematic and equitable implementation of evidence based strategies for cancer prevention, early detection and management of patients with cancer. 33% of the cancer burden could be reduced if detected early and treated adequately. The WHO concludes that, early diagnosis of cancers could save the developed world an average of €40 billion per year on medical costs and €80 billion per year on realized productivity. The direct savings on medical treatment alone would be more than €10.000 per patient if early detection was possible. Early cancer diagnosis today consists of recognition of some of the ‘early’ signs by the patient themselves or detection from screenings carried out on specific population groups. If something suspicious is found the next step is to perform a blood analysis and/or to look with non-invasive imaging techniques. Current imaging techniques are widely used in diagnostic procedures but they cannot give conclusive evidence of cancer. Today, only a biopsy and the subsequent pathologist’s interpretation can give a definitive diagnosis of cancer and this is not always enough EDOCAL will use a tunable blue laser to selectively excite an accumulated photo sensitizer, called proto-porphyrin. This sensitizer is taken by the patient to enhance contrast between healthy and cancerous tissue. Reflected light is filtered using state of the art ultra narrow photonic crystal technology. Initial studies have shown that it is possible to detect cancerous tissue using blue light in combination with FDA approved sensitizers (ALA-5 and Proto-Porphyrin). This tool will be based on the principle of preferential retention of proto-porphyrin by cancer cells. The purpose of this project is to create a breakthrough tool for early cancer detection by combining state of the art laser and imaging technology with leading medical research.'

Introduzione (Teaser)

Early detection of cancer saves lives, improves quality of life and reduces health care cost. According to the World Health Organisation the burden of cancer can be significantly reduced by implementation of evidence based strategies for prevention, early detection and management of patients with cancer.